Adrian Liston (@LabListon) header
Adrian Liston (@LabListon) profile picture

🇦🇺🇧🇪🇬🇧👨‍🔬🌈 Professor of Pathology & Head of Immunology at @Cambridge_Uni. Fellow & Welfare Tutor at @Catz_Cambridge. Founder & CSO at Aila Biotech.

Cambridge, England
Joined December 2018
I just had to show off my latest purchase - the only water bottle around for lovers of lymph! etsy.com/uk/shop/AisforAntib…
10
963
Can you actually get mega-rich through a career in science? Is biohacking in a DIY lab a sensible option? Why is there a cat playing chess? Should you just drop out of the rat race and take up a career in landscaping? These questions and more are answered!
1
137
Does it actually change your life if your high school grades weren't so good? Do you fall behind by taking on a tech job in #pharma rather than doing a #PhD? How bad would it actually be to fudge the results a little for a paper? Would that #StartUp idea have actually worked?
1
1
249
Our new book "The Professor, the Pipette & the Path Not Taken", explores alternative careers and lives that you could have taken With more than 250 different pathways and 10 unique endings, this unique branching story allows you to choose your path through science and life
1
1
7
504
Ever wonder how your career (and life!) could have turned out differently if you had picked that PhD project in London instead, or gone into #patientadvocacy rather than a #postdoc? What different lives could you have lived? Now you can find out! amazon.co.uk/Professor-Pipet…
1
4
1
24
7,675
I'm officially an expert in failing! I was asked to give the opening keynote today for a @CRUKCamCentre conference, speaking on the topic "Failing in Science"
1
22
135
12,075
If you want to learn more about cytokine delivery to modify the lung immune environment, but don't have time to read our full paper at @SciImmunology, here is a short (5 minute) explainer! science.org/doi/10.1126/scii…
9
30
3,531
Sometimes science leads us to unexpected places. For example, work we started during the COVID lockdown, may help treating the "Curse of the Pharaohs" Read all about it at @SciImmunology PS, we don't support tomb-robbing of ancient Egyptian burial sites science.org/doi/10.1126/scii…
2
651
The best part is, because we only altered the lung immunology, the anti-viral responses generated in the LN were intact, so we could reduce lung inflammation without giving the infection a free-pass. This is why tissue immunology has such potential - only hit the site needed!
1
2
111
So we teamed up with @KULeuvenU and tested our AAV-cytokine delivery approach in coinfected (IAPA) mice. Success! In every measure we tested, our treatment reduced severity down from fatal respiratory failure down closer to a regular flu infection.
1
3
112
But Aspergillus is a hidden killer. The Wauters, Vande Velde and Humblet-Baron teams at @KULeuvenU found that coinfection of influenza and aspergillus is extremely deadly, with an ICU mortality rate of >50%, >70% if immunocompromised. Likewise, coinfection in mice is lethal.
1
2
89
Aspergillus is a fungus common in decaying soil, that can infect the lung. For healthy individuals it is rarely a problem, and is easily cleared Fun fact: Aspergillus may be the "Curse of the Pharaohs" as Egyptian tombs were full of spores, infecting tomb robbers at high dose
1
2
99
We never ended up testing it in SARS-CoV2 infection - by that point the #vaccine had come along. But COVID isn't the only important lung infection. You might not even have heard of one of the most deadly: Influenza-Associated Pulmonary Aspergillosis (IAPA)
1
4
101
The system works great! AAV6.2.CC10 driving #IL2 production gives an expansion of #lung #Tregs without impacting other sites, even draining LN. And it is not just IL2 - in the same way we can drive #IL10 or #IL1RA in the lung without altering systemic levels. Pick your own cargo!
1
2
106
It took quite some trial and error, but eventually we found that intranasal delivery of AAV6.2 capsid with the CC10 promoter drove tight expression of our cargo by club cells, limited to the lung tissue. Gorgeous imaging from the team of @RegisJoulia
1
3
112
This story started during the COVID pandemic. Our first Cambridge PhD students joined during lockdown, and a talented student, @TombiMakuyana, wanted to work on a potential therapeutic. Only essential people (James Dooley, not me!) could be in the lab, but they started working
1
6
958